Back

Efficacy and safety of sacubitril/allisartan plus amlodipine in hypertensive patients not adequately controlled by amlodipine or sacubitril/allisartan monotherapy: the SALUS study

30 August 2026 (17:30 - 17:45)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: hypertension Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Jianping Li

Peking University First Hospital, Beijing (China)

3 More presentations in this session

Presentation thumbnail
The ELFIE-HYPERTENSION Trial: An international randomized multicenter trial of an artificial intelligence enhanced and gamified mobile health intervention for hypertension management
Doctor K. Santo (Sao Paulo, BR)
Slides
Presentation thumbnail
Blood pressure management with an artificial intelligence-enhanced app and wearable devices: My Intelligent Cardiac Assistant (MICArdiac) Randomised Controlled Trial
Doctor L. Laranjo (Sydney, AU)
Slides
Presentation thumbnail
Chemical adherence testing-guided intervention is cost-effective in management of non-adherence to antihypertensive treatment - life-time evaluation of OUTREACH Study
Doctor S. Hames-Fathi (Manchester, GB)

Access the full session

Session thumbnail
Late-Breaking Clinical Science: hypertension
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:30 CET
You may be interested in
thumbnail
Congress Presentation
Sacubitril/Valsartan efficacy on functional, laboratory, echocardiographic parameters: a real-world study
29 June 2021
thumbnail
Webinar
CHT-CCP Webinar: Translating the hypertension guidelines in our daily practice: a case-based clinical approach
28 May 2020
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
25 August 2023
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources